Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Accurately predicting the risk of death, recurrence, and metastasis of patients with nasopharyngeal carcinoma (NPC) is potentially important for personalized diagnosis and treatment. Survival outcomes of patients vary greatly in distinct stages of NPC. Prognostic models of stratified patients may aid in prognostication.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To explore the prognostic performance of MRI‐based radiomics signatures in stratified patients with NPC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>Seven hundred and seventy‐eight patients with NPC (T1‐2 stage: 298, T3‐4 stage: 480; training cohort: 525, validation cohort: 253).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>Fast‐spin echo (FSE) axial T1‐weighted images, FSE axial T2‐weighted images, contrast‐enhanced FSE axial T1‐weighted images at 1.5 T or 3.0 T.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Radiomics signatures, clinical nomograms, and radiomics nomograms combining the radiomic score (Radscore) and clinical factors for predicting progression‐free survival (PFS) were constructed on T1‐2 stage patient cohort (A), T3‐4 stage patient cohort (B), and the entire dataset (C).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Least absolute shrinkage and selection operator (LASSO) method was applied for radiomics modeling. Harrell's concordance indices (C‐index) were employed to evaluate the predictive power of each model.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Among 4,410 MRI‐extracted features, we selected 16, 16, and 14 radiomics features most relevant to PFS for Models A, B, and C, respectively. Only 0, 1, and 4 features were found overlapped between models A/B, A/C, and B/C, respectively. Radiomics signatures constructed on T1‐2 stage and T3‐4 stage patients yielded C‐indices of 0.820 (95% confidence interval [CI]: 0.763–0.877) and 0.726 (0.687–0.765), respectively, which were larger than those on the entire validation cohort (0.675 [0.637–0.713]). Radiomics nomograms combining Radscore and clinical factors achieved significantly better performance than clinical nomograms (<i>P</i> < 0.05 for all). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The selected radiomics features and prognostic performance of radiomics signatures differed per the type of NPC patients incorporated into the models. Radiomics models based on pre‐stratified tumor stages had better prognostic performance than those on unstratified dataset.</p><p><b>Level of Evidence</b>: 4 </p><p><b>Technical Efficacy Stage</b>: 5 </p></section>

Correction to: Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups

Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups

Corrigendum: Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis.

Correction to: A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

[Corrigendum] miR‐182‐5p contributes to radioresistance in naso-pharyngeal carcinoma by regulating BNIP3 expression

Correction: Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Radiomic-Based Quantitative Ct Analysis Of Pure Ground-Glass Nodules To Predict The Invasiveness Of Lung Adenocarcinoma (Vol 10, 872, 2020)

Author Correction: Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients

Correction to: The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype

Correction To: EBV-miR-BART8-3p Induces Epithelial-Mesenchymal Transition and Promotes Metastasis of Nasopharyngeal Carcinoma Cells Through Activating NF-κB and Erk1/2 Pathways

Correction: Solitary Ground-Glass Opacity Nodules of Stage IA Pulmonary Adenocarcinoma: Combination of 18F-FDG PET/CT and High-Resolution Computed Tomography Features to Predict Invasive Adenocarcinoma.

MRI-based radiomics models can improve prognosis prediction for nasopharyngeal carcinoma with neoadjuvant chemotherapy

Corrigendum: Comparison of Clinical Outcomes Between Cone Beam CT-guided Thermal Ablation and Helical Tomotherapy in Pulmonary Metastases from Hepatocellular Carcinoma

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer

Differences in Radiomics Signatures Between Patients with Early and Advanced T‐Stage Nasopharyngeal Carcinoma Facilitate Prognostication

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: An ultrasonic-based radiomics nomogram for distinguishing between benign and malignant solid renal masses.

Radiomics-based lymph nodes prognostic models from three MRI regions in nasopharyngeal carcinoma

Correction To: BM-MSC-derived Exosomes Alleviate Radiation-Induced Bone Loss by Restoring the Function of Recipient BM-MSCs and Activating Wnt/β-catenin Signaling